Immune cells may fend off Alzheimer disease

被引:42
作者
Britschgi, Markus [1 ]
Wyss-Coray, Tony
机构
[1] Stanford Univ, Sch Med, Dept Neurol & Neurol Sci, Stanford, CA 94305 USA
[2] Vet Affairs Palo Alto Hlth Care Syst, Geriatr Res Educ & Clin Ctr, Palo Alto, CA 94304 USA
关键词
D O I
10.1038/nm0407-408
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Chemokines in the brain recruit immune cells from the blood or from within the brain. Disrupting this line of communication exacerbates disease in mouse models of Alzheimer disease (pages 432-438).
引用
收藏
页码:408 / 409
页数:3
相关论文
共 13 条
  • [1] Inflammation and Alzheimer's disease
    Akiyama, H
    Barger, S
    Barnum, S
    Bradt, B
    Bauer, J
    Cole, GM
    Cooper, NR
    Eikelenboom, P
    Emmerling, M
    Fiebich, BL
    Finch, CE
    Frautschy, S
    Griffin, WST
    Hampel, H
    Hull, M
    Landreth, G
    Lue, LF
    Mrak, R
    Mackenzie, IR
    McGeer, PL
    O'Banion, MK
    Pachter, J
    Pasinetti, G
    Plata-Salaman, C
    Rogers, J
    Rydel, R
    Shen, Y
    Streit, W
    Strohmeyer, R
    Tooyoma, I
    Van Muiswinkel, FL
    Veerhuis, R
    Walker, D
    Webster, S
    Wegrzyniak, B
    Wenk, G
    Wyss-Coray, T
    [J]. NEUROBIOLOGY OF AGING, 2000, 21 (03) : 383 - 421
  • [2] Alzheimer's disease
    Blennow, Kaj
    de Leon, Mony J.
    Zetterberg, Henrik
    [J]. LANCET, 2006, 368 (9533) : 387 - 403
  • [3] Mechanisms of disease - The many roles of chemokines and chemokine receptors in inflammation
    Charo, IF
    Ransohoff, RM
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2006, 354 (06) : 610 - 621
  • [4] Ccr2 deficiency impairs microglial accumulation and accelerates progression of Alzheimer-like disease
    El Khoury, Joseph
    Toft, Michelle
    Hickman, Suzanne E.
    Means, Terry K.
    Terada, Kinya
    Geula, Changiz
    Luster, Andrew D.
    [J]. NATURE MEDICINE, 2007, 13 (04) : 432 - 438
  • [5] Chronic expression of monocyte chemoattractant protein-1 in the central nervous system causes delayed encephalopathy and impaired microglial function in mice
    Huang, DR
    Wujek, J
    Kidd, G
    He, TT
    Cardona, A
    Sasse, ME
    Stein, EJ
    Kish, J
    Tani, M
    Charo, IF
    Proudfoot, AE
    Rollins, BJ
    Handel, T
    Ransohoff, RM
    [J]. FASEB JOURNAL, 2005, 19 (07) : 761 - 772
  • [6] Identification of the major Aβ1-42-degrading catabolic pathway in brain parenchyma:: Suppression leads to biochemical and pathological deposition
    Iwata, N
    Tsubuki, S
    Takaki, Y
    Watanabe, K
    Sekiguchi, M
    Hosoki, E
    Kawashima-Morishima, M
    Lee, HJ
    Hama, E
    Sekine-Aizawa, Y
    Saido, TC
    [J]. NATURE MEDICINE, 2000, 6 (02) : 143 - 150
  • [7] Enhanced proteolysis of β-amyloid in APP transgenic mice prevents plaque formation, secondary pathology, and premature death
    Leissring, MA
    Farris, W
    Chang, AY
    Walsh, DM
    Wu, XN
    Sun, XY
    Frosch, MP
    Selkoe, DJ
    [J]. NEURON, 2003, 40 (06) : 1087 - 1093
  • [8] Aβ42 is essential for parenchymal and vascular amyloid deposition in mice
    McGowan, E
    Pickford, F
    Kim, J
    Onstead, L
    Eriksen, J
    Yu, C
    Skipper, L
    Murphy, MP
    Beard, J
    Das, P
    Jansen, K
    DeLucia, M
    Lin, WL
    Dolios, G
    Wang, R
    Eckman, CB
    Dickson, DW
    Hutton, M
    Hardy, J
    Golde, T
    [J]. NEURON, 2005, 47 (02) : 191 - 199
  • [9] Chemokines, mononuclear cells and the nervous system: heaven (or hell) is in the details
    Rebenko-Moll, Natalia M.
    Liu, LiPing
    Cardona, Astrid
    Ransohoff, Richard M.
    [J]. CURRENT OPINION IN IMMUNOLOGY, 2006, 18 (06) : 683 - 689
  • [10] Bone marrow-derived microglia play a critical role in restricting senile plaque formation in Alzheimer's disease
    Simard, AR
    Soulet, D
    Gowing, G
    Julien, JP
    Rivest, S
    [J]. NEURON, 2006, 49 (04) : 489 - 502